Opinion

Video

Persistence and Discontinuation Rates for Non-Statin Therapies in ASCVD

Author(s):

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP,Kate Cabral, PharmD, BCCP, FACC, FCCP

Clinical insights on how real-world treatment persistence and discontinuation rates compare between the various non-statin therapies and the factors that contribute to these differences.

Related Videos
5 experts in this video
5 experts in this video
Image credit: Jack Fotografo | stock.adobe.com
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
Related Content
Blue FDA approval stamp -- Image credit: B-design | stock.adobe.com
April 29th 2025

FDA Approves Upadacitinib for Adult Patients With Giant Cell Arteritis

Gillian McGovern, Associate Editor
Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations
April 29th 2025

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Alexandra Gerlach, Associate Editor
pregnant woman drinks pills. Pregnant woman holding a glass of water and vitamins for pregnant women in her hands, focus on the hand. Pregnancy health concept - Image credit: ProstoSvet | stock.adobe.com
April 23rd 2025

Study: Mineral and Vitamin Levels in Pregnancy Linked to Midlife Blood Pressure

Kennedy Ferruggia, Assistant Editor
The RIVAWAR Trial and ACS Guidelines for LV Thrombus
April 22nd 2025

The RIVAWAR Trial and ACS Guidelines for LV Thrombus

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Aislinn Antrim, Managing Editor
Woman with a migraine -- Image credit: BillionPhotos.com | stock.adobe.com
April 21st 2025

Migraine With Aura Plays Most Prominent Role in Women With Young-Onset CIS

Gillian McGovern, Associate Editor
Woman with cardiovascular disease -- Image credit: fizkes | stock.adobe.com
April 14th 2025

Study Finds Adverse Pregnancy Outcomes Mediate Association With CVD Risk, Prepregnancy Obesity in Midlife

Gillian McGovern, Associate Editor